Novolog Pharm-Up 1966 Ltd (NVLG) — Working Capital to Net Assets Ratio
Novolog Pharm-Up 1966 Ltd (NVLG) has a Working Capital to Net Assets ratio of -39.8% as of December 2025. Working capital of ILA-146.97 Million (current assets of ILA1.46 Billion minus current liabilities of ILA1.60 Billion) is measured against net assets of ILA368.90 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See net asset quality index of Novolog Pharm-Up 1966 Ltd to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Novolog Pharm-Up 1966 Ltd Working Capital to Net Assets (2014–2025)
This chart shows how Novolog Pharm-Up 1966 Ltd's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of December 2025, the ratio stands at -39.8%, reflecting working capital of ILA-146.97 Million against net assets of ILA368.90 Million ILA. Check tangible equity quality of Novolog Pharm-Up 1966 Ltd to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Novolog Pharm-Up 1966 Ltd (2014–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Novolog Pharm-Up 1966 Ltd from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Novolog Pharm-Up 1966 Ltd market capitalisation.
| Year | WC/NA Ratio | Working Capital (ILA) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -39.8% | ILA-146.97 Million | ILA368.90 Million | ILA1.46 Billion | ILA1.60 Billion | ▼ -15.4 pp |
| 2024 | -24.5% | ILA-93.45 Million | ILA382.14 Million | ILA2.37 Billion | ILA2.46 Billion | ▼ -4.7 pp |
| 2023 | -19.8% | ILA-78.39 Million | ILA396.12 Million | ILA2.11 Billion | ILA2.18 Billion | ▼ -11.6 pp |
| 2022 | -8.2% | ILA-37.67 Million | ILA462.05 Million | ILA1.72 Billion | ILA1.76 Billion | ▼ -20.5 pp |
| 2021 | 12.3% | ILA52.94 Million | ILA430.23 Million | ILA1.74 Billion | ILA1.69 Billion | ▲ +21.0 pp |
| 2020 | -8.7% | ILA-25.64 Million | ILA295.67 Million | ILA1.71 Billion | ILA1.73 Billion | ▲ +5.8 pp |
| 2019 | -14.5% | ILA-38.12 Million | ILA263.78 Million | ILA1.68 Billion | ILA1.71 Billion | ▲ +48.9 pp |
| 2018 | -63.3% | ILA-64.37 Million | ILA101.61 Million | ILA1.53 Billion | ILA1.60 Billion | ▲ +16.3 pp |
| 2017 | -79.7% | ILA-68.27 Million | ILA85.71 Million | ILA1.62 Billion | ILA1.69 Billion | ▼ -52.2 pp |
| 2016 | -27.5% | ILA-19.44 Million | ILA70.68 Million | ILA1.42 Billion | ILA1.44 Billion | ▼ -62.1 pp |
| 2015 | 34.6% | ILA35.38 Million | ILA102.34 Million | ILA1.57 Billion | ILA1.54 Billion | ▲ +8.7 pp |
| 2014 | 25.8% | ILA22.42 Million | ILA86.77 Million | ILA1.25 Billion | ILA1.23 Billion | — |